Abbott's sales and earnings per share growth
ABT
Statements (8)
- Neutral
Abbott Laboratories reaffirmed its adjusted earnings outlook for the full-year 2026.
- Bullish
Abbott Laboratories reported net sales of $13.01 billion in the third quarter of fiscal 2026.
- Bullish
Abbott Laboratories' net sales grew 14.5% year-over-year in the third quarter of fiscal 2026.
- Bullish
Comparable sales for Abbott Laboratories grew 7% in the third quarter of fiscal 2026.
- Bullish
Abbott reported adjusted diluted EPS of $1.42.
- Bullish
Abbott reported comparable sales growth of 7.0 percent in the third quarter.
- Bullish
Abbott reported third-quarter 2026 sales growth of 14.5 percent.
- Bullish
Abbott Laboratories' continuous glucose monitoring sales grew 9.5% excluding currency effects in the second quarter of 2026